Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $1... (.Geoffrey Allan President and CEO of Ins...)

Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million

Date:2/12/2009

. Geoffrey Allan, President and CEO of Insmed. "We are pleased that over the past two years our team has been successful in developing such a valuable asset, which, as a result of this agreement, will generate a substantial return to the Company."

"This transaction will transform and strengthen our balance sheet in a completely non-dilutive fashion, and provides us with substantial financial flexibility in a market where cash, especially for small biotech companies, is scarce," continued Dr. Allan.

The proceeds from the transaction will be used to support the continued development of IPLEX(TM), and the Company will carefully evaluate other options, which could include the distribution of a portion of the cash to shareholders.

As of December 31, 2008, Insmed had $2.4 million in cash on hand with an ongoing net cash burn of approximately $1.2 million per month. This transaction, in accordance with Virginia corporate law, does not require a shareholder vote, though it is conditional on certain closing requirements, including obtaining necessary consents.

RBC Capital Markets served as exclusive financial advisor to Insmed on the transaction and the review of strategic alternatives, and provided a fairness opinion to the Company's Board of Directors.

Conference Call

Insmed will host a conference call today at 8:30 AM ET in order to further discuss this transaction. To participate in today's 8:30 AM ET live conference call, please dial 800-891-3155 (U.S. callers) or 617-597-5527 (international callers), and provide passcode 54149478. A live webcast of the call will also be available at: http://phx.corporate-ir.net/playerlink.zhtml?c=122332&s=wm&e=2097821

Please allow extra time prior to the webcast to register, download and install any n
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference
2. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
3. NASDAQs Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmeds Compliance Date to March 20, 2009
4. Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule
5. Insmed to Seek Shareholder Approval for Reverse Split
6. Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants
7. Insmed to Present at Biosimilars 2008 Conference
8. Insmed to Present at BioPharm Asia 2008 Conference
9. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
10. Insmed CEO to Present at Drug Discovery & Development Conference
11. Insmed to Host Second Quarter 2008 Conference Call

Post Your Comments:

(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...

(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...

(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...

(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...

[0] BioMS Medical Announces 2009 Year End Results [0] PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 [0] Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher [0] Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals

... does a nearly 100-year-old greeting card company have to ... would seem from my recent conversation with Bryan Biniak, ... , ,In just under 100 days, AGmobile has ... of American Greetings, arguably the most progressive technology innovator ...

... the financial technology subsidiary of Marshall & Ilsley ... agreement to acquire the Kirchman Corporation , ... Corporation is a provider of automation software and ... Corporation will become a Metavante subsidiary and operate ...

... MADISON - Third Wave Technologies announced a new ... at the 20th Annual Clinical Virology Symposium in Florida. , ... disease in the United States and affects 4 million Americans, ... statement. The new reagents, part of Third Waves Invader product ...

Other Biology Technology:Mobile content: Where brand meets markets 2 Mobile content: Where brand meets markets 3 Mobile content: Where brand meets markets 4 Metavante acquires Florida banking corporation 2

Mobile content: Where brand meets markets Metavante acquires Florida banking corporation Third Wave releases reagents for Hepatitis C testing

(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...

(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...

(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...

Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2 Tryptophan-enriched diet reduces pig aggression 2 Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1 Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2 Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1 Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3

[0] Females shut down male-male sperm competition in leafcutter ants [0] Tryptophan-enriched diet reduces pig aggression [0] GenWay Biotech extends the You Test You program overseas

... #1 FOR IMMEDIATE RELEASE , An advance in solving ... Research , Scientists in Ohio are ... for more than one million machinists in the United ... contaminated metalworking fluids. Those fluids become airborne during machining ...

... Ariz. The International Institute for Species Exploration at ... scientists responsible for species exploration and classification ... 2008. , On the list are a pea-sized seahorse, ... top 10 new species also include the very tiny ...

... N.C. An emerging form of the pathogenic yeast Candida ... a test tube, even though it,s missing the genes for ... according to Duke University Medical Center researchers. , ... species, evolutionary success," said Joseph Heitman, M.D., Ph.D., director of ...

American Chemical Society's Weekly PressPac -- May 20, 2009 Scientists announce top 10 new species; issue SOS Yeast missing sex genes undergo unexpected sexual reproduction

... of Use : GeneTraffic is built to ... biological research. GeneTraffic provides visual and computational ... data prior to analysis. , Data ... projects using the MIAME (Minimum Information About ...

... are rigid macroporous hydrophilic media. The rigid ... moderate pressures, while the macroporous beads enhance ... matrix reduces nonspecific binding. Macro-Prep High Q ... with very high flow rates and resolution. ...

... cocktail of 3 siRNAs specifically targeted to ... popular product. The siTrio reagent guarantees you ... target gene when used under standard conditions ... of optimal transfection with one of B-Bridges ...

... 25-Hydroxy Vitamin D kit is an ... of 25-hydroxyvitamin D (25-OH D) and ... or plasma. Our patented DIRECT assay ... precipitation and centrifugation and therefore facilitates ...

Biology Products:

GeneTraffic from Iobion Informatics Macro-Prep High Q Support, 500 ml from Bio-Rad Human siTrio from B-Bridge International Human 25-Hydroxy Vitamin D EIA Kit from IDS Ltd

Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $1...(.Geoffrey Allan President and CEO of Ins...)